Results 211 to 220 of about 36,553 (255)

Packaging Systems for Adeno-associated Virus Vectors

1996
The promise and hopes that gene therapy vectors derived from adeno-associated virus (AAV) will make the leap from the laboratory bench to the clinic bedside are thoroughly described in this volume of Current Topics of Microbiology and Immunology. As more investigators enter this rapidly growing field, AAV’s ability to deliver genes of therapeutic ...
openaire   +2 more sources

High-Throughput In Vitro , Ex Vivo, and In Vivo Screen of Adeno-Associated Virus Vectors Based on Physical and Functional Transduction

Human Gene Therapy, 2020
Adrian Westhaus, Cindy Zhu, Anai Gonzalez-Cordero   +2 more
exaly  

Optimized Adeno-Associated Virus Vectors for Efficient Transduction of Human Retinal Organoids

Human Gene Therapy, 2021
Stylianos Michalakis, Mike O Karl, Manuela Völkner   +2 more
exaly  

Adeno-Associated Virus and Vector

2016
Chen Ling, Daniel Zhang
openaire   +1 more source

Recombinant adeno-associated virus vectors

2020
MCCOY DANIEL, BERRY GARRETT E
openaire   +3 more sources

Towards Clinical Implementation of Adeno-Associated Virus (AAV) Vectors for Cancer Gene Therapy: Current Status and Future Perspectives

Cancers, 2020
Ulrich Hacker, Hildegard Büning, Dorota Kaniowska   +2 more
exaly  

Adeno-associated virus (AAV) vectors in cancer gene therapy

Journal of Controlled Release, 2016
David Schaffer, Jorge Santiago-Ortiz, Jorge L Santiago-Ortiz   +2 more
exaly  

Recombinant adeno-associated virus vectors for gene therapy

Expert Opinion on Biological Therapy, 2004
Terence Flotte, Thomas J Conlon
exaly  

Recombinant adeno-associated virus vectors in the treatment of rare diseases

Expert Opinion on Orphan Drugs, 2015
Eric Hastie, R Jude Samulski
exaly  

Helper virus-free, optically controllable, and two-plasmid-based production of adeno-associated virus vectors of serotypes 1 to 6

Molecular Therapy, 2003
Dirk Grimm, Mark Kay
exaly